Royal Bank Of Canada Synthetic Biologics, Inc. Transaction History

Royal Bank Of Canada

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$2.3 - $4.3 $23,000 - $43,000	-10,000 Reduced 99.29%	72 $0
Q4 2021 Feb 14, 2022	BUY	$2.7 - $4.5 $26,689 - $44,482	9,885 Added 5286.1%	10,072 $3,000
Q3 2021 Nov 15, 2021	BUY	$4.3 - $5.8 $494 - $667	115 Added 159.72%	187 $0
Q2 2021 Aug 16, 2021	BUY	$4.6 - $7.2 $331 - $518	72 New	72 $0

Ticker SYN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,844,100
Market Cap $9.51M
Description
Synthetic Biologics, Inc., a clinical-stage company, develops therapeutics to treat diseases in areas of high unmet need. The company's lead product candidates include SYN-004 designed to degrade various commonly used intravenous beta-lactam antibiotics in gastrointestinal (GI) tract for the prevention of microbiome damage, clostridium difficile...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.